Skip to main content
Clinical Trials/JPRN-UMIN000041120
JPRN-UMIN000041120
Not Yet Recruiting
N/A

Improvement of psychiatric symptoms and social function of aripiprazole long acting injection for outpatient schizophrenia - Improvement of psychiatric symptoms and social function of aripiprazole long acting injection for outpatient schizophrenia

Sanzyukai Medical Corporation Naomasa Clinic0 sites140 target enrollmentJuly 16, 2020
ConditionsSchizophrenia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
Sanzyukai Medical Corporation Naomasa Clinic
Enrollment
140
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 16, 2020
End Date
August 31, 2020
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Sanzyukai Medical Corporation Naomasa Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who do not meet the above selection criteria.

Outcomes

Primary Outcomes

Not specified

Similar Trials